Reacts in: Human
No Available References
- Honolulu: FDA Approval in Sight for 18F Amyloid Tracer Florbetapir?
- Honolulu: Intranasal Insulin Trial Claims Promise in MCI, AD
- What Do Clinicians Say? Peers Welcome Revised Criteria
- BDNF the Next AD Gene Therapy?
- Honolulu: The Missing Link? Tau Mediates Aβ Toxicity at Synapse
- Revised Criteria for Preclinical AD, Exactly as Presented
- Noisy Response Greets Revised Diagnostic Criteria for AD
- Honolulu: TrialMatch Launched as AD Is Becoming “Desktop” Disease
- Honolulu: Tomm40 Reported to Track With Brain Atrophy, Cognition
- Honolulu: Wake-Up Call—Aβ Clearance, Not Production, Awry in AD
- Support Cast: Neural Stem Cell BDNF Prompts Memory in AD Mice
- Mouse Screen Yields Pro-neurogenesis Elixir
- Baby Steps Toward Cell Therapies for ALS